Breaking Finance News

A report released today by Benchmark about Natus Medical (NASDAQ:BABY) bumps the target price to $55.00

Boasting a price of $39.91, Natus Medical (NASDAQ:BABY) traded 1.58% higher on the day. With the last stock price close up 8.38% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. The company has recorded a 50-day moving average of $40.44 and a 200-day moving average of $36.82. 485,955 shares of the stock were exchanged, up from an average trading volume of 309,662

Benchmark upped the price target of Natus Medical (NASDAQ:BABY) to $55.00 indicating a possible upside of 0.38%.

See Chart Below

Natus Medical (NASDAQ:BABY)

With a total market value of $0, Natus Medical has price-earnings ratio of 34.41 with a 52 week low of $29.54 and a 52 week high of $51.05 .

Also covering Natus Medical's price target, a total of 2 analysts have released a research note on Natus Medical. The average stock price target is $42.00 with 1 brokerage rating the company a strong buy, two firms rating the stock a buy, 0 equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and lastly zero analysts rating the company a sell.

General Company Details For Natus Medical (NASDAQ:BABY)

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *